Top

Published in:

01-02-2013 | Research Article

2-Deoxy-d-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells

Authors: Venkata Reddy Bandugula, Rajendra Prasad N.

Published in: Tumor Biology | Issue 1/2013

Abstract

Previously, we reported the radiosensitizing potential of the combination of 2-deoxy-d-glucose (2DG) and ferulic acid (FA) in NCI-H460 non-small cell lung carcinoma cells in vitro. The present study aims to explore the relevant mechanism of cell death induced by the combination of 2DG and FA along with irradiation in NCI-H460 cells. Incubation of NCI-H460 cells with the combination of 2DG and FA for 24 h before irradiation upregulated the expression of proapoptotic proteins p53 and Bax. Combination of 2DG and FA also increased the levels of p21 and GADD45A in NCI-H460 cells. DNA repair inhibition is expected to be a possible mechanism for the radiosensitization observed, which is evidenced by the downregulation of radiation-induced ataxia-telangiectasia mutated gene expression upon treatment with 2DG and/or FA. Moreover, Western blotting analysis of NF-κB and caspase-3 revealed the involvement of apoptotic signals in the cytotoxicity exhibited by the combination of 2DG and FA. Cell cycle analysis data also showed the increased percentage of Sub-G₀ phase cells upon treatment with the combination of 2DG and FA before irradiation. Taken together, the results of our study clearly suggested that the cell death induced by the combination of 2DG and FA along with irradiation would involve alteration in expression of p53, p21, NF-κB, Bax, and caspase-3, indicating oxidative mechanism in NCI-H460 cells.

Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–94.PubMed

Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;350(4):379–92.PubMedCrossRef

Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT. Over expression of Glut1 and Glut3 in stage I non small cell lung carcinoma is associated with poor survival. Cancer. 1997;80(6):1046–51.PubMedCrossRef

Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–14.PubMedCrossRef

Weber G. Enzymology of cancer cells. N Engl J Med. 1997;296(9):541–51.

Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-d-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer. 2002;87(7):805–12.PubMedCrossRef

Dwarakanath BS, Adhikari JS, Khaitan D, Chandna S, Mathur R, Ravindranath T. Growth inhibition and induction of apoptosis by 2-deoxy-d-glucose in human squamous carcinoma cell lines. Biomedicine. 2005;24:36–47.

Swamy RK, Manickam J, Adhikari JS, Dwarakanath BS. Glycolytic inhibitor, 2-deoxy-d-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro. Indian J Exp Biol. 2005;43(8):686–92.PubMed

Nelson CA, Wang JQ, Leav I, Crane PD. The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3 H-2-deoxyglucose retention in murine tumor models. Nucl Med Biol. 1996;23(4):533–41.PubMedCrossRef

10.

Maher JC, Krishan A, Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol. 2004;53(2):116–22.PubMedCrossRef

11.

Heminger K, Jain V, Kadakia M, Dwarakanath B, Berberich SJ. Altered gene expression induced by ionizing radiation and glycolytic inhibitor 2-deoxy-glucose in a human glioma cell line: implications for radio sensitization. Cancer Biol Ther. 2006;5(7):815–23.PubMedCrossRef

12.

Coleman MC, Asbury CR, Daniels D, Du J, Aykin-Burns N, Smith BJ, et al. 2-deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radic Biol Med. 2008;44(3):322–31.PubMedCrossRef

13.

Dwarkanath BS, Zolzer F, Chandana S, Bauch T, Adhikari JS, Muller WU, et al. Heterogeneity in 2-deoxy-d-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Int J Radiat Oncol Biol Phys. 2001;50(4):1051–61.PubMedCrossRef

14.

Lee KW, Lee HJ. The roles of polyphenols in cancer chemoprevention. Biofactors. 2006;26(2):105–21.PubMedCrossRef

15.

Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal. 2005;7(11–12):1630–47.PubMedCrossRef

16.

Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579–91.PubMedCrossRef

17.

Reddy BV, Prasad NR. 2-deoxy-d-glucose combined with ferulic acid enhances radiation response in non-small cell lung carcinoma cells. Cent Eur J Biol. 2011;6(5):743–55.CrossRef

18.

Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88(3):323–31.PubMedCrossRef

19.

Schmidt-Ullrich RK. Molecular targets in radiation oncology. Oncogene. 2003;22(37):5730–3.PubMedCrossRef

20.

Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, et al. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res. 2003;159(3):283–300.PubMedCrossRef

21.

Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene. 2003;22(37):5834–47.PubMedCrossRef

22.

Karin M, Cao Y, Greten F, Li Z. NF-kB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301–10.PubMedCrossRef

23.

Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, et al. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis. 2005;26(7):1182–95.PubMedCrossRef

24.

Leu TH, Maa MC. The molecular mechanisms for the antitumorigenic effect of curcumin. Curr Med Chem Anticancer Agents. 2002;2(3):357–70.PubMedCrossRef

25.

Rupinder SK, Gurpreet AK, Manjeet S. Cell suicide and caspases. Vasc Pharmacol. 2007;46(6):383–93.CrossRef

26.

Okouoyo S, Herzer K, Ucur E, Mattern J, Krammer PH, Debatin KM, et al. Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo. Int J Cancer. 2004;108(4):580–7.PubMedCrossRef

27.

Weigel TL, Lotze MT, Kim PK, Amoscato AA, Luketich JD, Odoux C. Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity. J Thorac Cardiovasc Surg. 2000;119(4 pt 1):795–803.PubMedCrossRef

28.

Krug LM, Miller VA, Filippa DA, Venkatraman E, Ng KK, Kris MG. Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine. Lung Cancer. 2003;39(2):139–43.PubMedCrossRef

29.

Porebska I, Wyrodek E, Kosacka M, Adamiak J, Jankowska R, Harłozińska-Szmyrka A. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. In Vivo. 2006;20(5):599–604.PubMed

30.

Sakata K, Someya M, Matsumoto Y, Hareyama M. Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity. Radiat Med. 2007;25(9):433–8.PubMedCrossRef

31.

Xing J, Wu X, Vaporciyan AA, Spitz MR, Gu J. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with non small cell lung cancer. Cancer. 2008;112(12):2756–64.PubMedCrossRef

32.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001;25(4):402–8.PubMedCrossRef

33.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed

34.

Li L, Story M, Legerski R. Cellular responses to ionizing radiation damage. Int J Radiat Oncol Biol Phys. 2001;49(4):1157–62.PubMedCrossRef

35.

Zhang XD, Deslandes E, Villedieu M, Poulain L, Duval M, Gauduchon P, et al. Effect of 2-deoxy-d-glucose on various malignant cell lines in vitro. Anticancer Res. 2006;26(5A):3561–6.PubMed

36.

Sinthupibulyakit C, Grimes KR, Domann FE, Xu Y, Fang F, Ittarat W, et al. p53 is an important factor for the radiosensitization effect of 2-deoxy-d-glucose. Int J Oncol. 2009;35(3):609–15.PubMed

37.

Cao C, Shinohara ET, Subhawong TK, Geng L, Woon Kim K, Albert JM, et al. Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2. Mol Cancer Ther. 2006;5(2):411–7.PubMedCrossRef

38.

Desaint S, Luriau S, Aude JC, Rousselet G, Toledano MB. Mammalian antioxidant defenses are not inducible by H2O2. J Biol Chem. 2004;279(30):31157–63.PubMedCrossRef

39.

El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817–25.PubMedCrossRef

40.

Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 1995;377(6549):552–7.PubMedCrossRef

41.

Zou C, Guan Y, Zou C, Wang J, Wang LE, Liebert M, Grossman HB, Wei Q. N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines. Cancer Lett. 2002;180(2):131–7.PubMedCrossRef

42.

Sheikh MS, Hollander MC, Fornace Jr AJ. Role of GADD45 in apoptosis. Biochem Pharmacol. 2000;59(1):43–5.PubMedCrossRef

43.

Saha A, Kuzuhara T, Echigo N, Fujii A, Suganuma M, Fujiki H. Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of growth arrest and DNA damage inducible genes 45 and 153. Biol Pharm Bull. 2010;33(8):1291–9.PubMedCrossRef

44.

Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis—the p53 network. J Cell Sci. 2003;116(20):4077–85.PubMedCrossRef

45.

Brady HJ, Salomons GS, Bobeldijk RC, Berns AJ. T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. EMBO J. 1996;15(6):1221–30.PubMed

46.

Li CR, Zhou Z, Zhu D, Sun YN, Dai JM, Wang SQ. Protective effect of paeoniflorin on irradiation-induced cell damage involved in modulation of reactive oxygen species and the mitogen-activated protein kinases. Int J Biochem Cell Biol. 2007;39(2):426–38.PubMedCrossRef

47.

Zagorodna O, Martin SM, Rutkowski DT, Kuwana T, Spitz DR, Knudson CM. 2-Deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines. Oncogene 2011: Epub 2011 Oct 10.

48.

Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 2002;512(1–3):334–40.PubMedCrossRef

49.

Stecca C, Gerber GB. Adaptive response to DNA-damaging agents: a review of potential mechanisms. Biochem Pharmacol. 1998;55(7):941–51.PubMedCrossRef

50.

Rotman G, Shiloh Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene. 1999;18(45):6135–44.PubMedCrossRef

51.

Lavin M, Shiloh Y. Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. Curr Opin Immunol. 1996;8(4):459–64.PubMedCrossRef

52.

Piret B, Schoonbroodt S, Piette J. The ATM protein is required for sustained activation of NF-kB following DNA damage. Oncogene. 1999;18(13):2261–71.PubMedCrossRef

53.

Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene. 2004;23(8):1599–607.PubMedCrossRef

54.

Lindholm PF, Bub J, Kaul S, Shidman VB, Kajdacsy-Balla A. The role of constitutive NF-kB activity in PC-3 human prostate cancer cell invasive behavior. Clin Exp Metastasis. 2000;18(6):471–9.PubMedCrossRef

55.

Nakayama H, Ikebe T, Beppu M, Shirasuna K. High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer. 2001;92(12):3037–44.PubMedCrossRef

56.

Pajonk F, Pajonk K, McBride WH. Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition. Int J Radiat Oncol Biol Phys. 2000;47(4):1025–32.PubMedCrossRef

57.

Li N, Banin S, Ouyang H, Li GC, Courtois G, Shiloh Y, et al. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J Biol Chem. 2001;276(12):8898–903.PubMedCrossRef

58.

Higuchi K, Mitsuhashi N, Saitoh J, Maebayashi K, Sakurai H, Akimoto T, et al. Caffeine enhanced radiosensitivity of rat tumor cells with a mutant-type p53 by inducing apoptosis in a p53-independent manner. Cancer Lett. 2000;152(2):157–62.PubMedCrossRef

59.

Yu Q, La Rose JH, Zhang HL, Pommier Y. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G₂ checkpoints and enhances apoptotic activity in HEK-293 cells. FEBS Lett. 2001;505(1):7–12.PubMedCrossRef

60.

Giammarioli AM, Gambardella L, Barbati C, Pietraforte D, Tinari A, Alberton M, et al. Differential effects of the glycolysis inhibitor 2-deoxy-d-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response. Int J Cancer 2011: Epub 2011 Sep 12.

61.

Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG. Genistein inhibits radiation-induced activation of NF-kB in prostate cancer cells promoting apoptosis and G₂/M cell cycle arrest. BMC Cancer. 2006;6:107.PubMedCrossRef

62.

Chen HW, Huang HC. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol. 1998;124(6):1029–40.PubMedCrossRef

63.

Hou YZ, Yang J, Zhao GR, Yuan YJ. Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II. Eur J Pharmacol. 2004;499(1–2):85–90.PubMedCrossRef

64.

Mackey MA, Ianzini F. Enhancement of radiation-induced mitotic catastrophe by moderate hyperthermia. Int J Radiat Biol. 2000;76(2):273–80.PubMedCrossRef

Title: 2-Deoxy-d-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells
Authors: Venkata Reddy Bandugula
Rajendra Prasad N.
Publication date: 01-02-2013
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 1/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-012-0545-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis

TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells

Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors

Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia

Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo

Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer